View source for Mycoplasma genitalium

{{short description|Species of bacterium}}
{{Italic title}}{{cs1 config|name-list-style=vanc}}
{{Speciesbox
| name = ''Mycoplasma genitalium''
| image = 3D Whole Cell (3D-WC) model of a Mycoplasma genitalium cell.jpg
| image_alt = 
| image_caption = 3D whole cell model of a ''Mycoplasma genitalium'' cell. Note this model does not include the terminal attachment organelle.
| genus = Mycoplasmoides
| species = genitalium
| authority = (Tully ''et al.'' 1983) Gupta ''et al.'' 2018<ref name=":5"/>
| synonyms = ''Mycoplasma genitalium'' Tully ''et al.'' 1983<ref name=tully83/>
| synonyms_ref = 
}}

'''''Mycoplasma genitalium''''' (also known as '''''MG'''''<ref>{{cite news |url=https://www.bbc.com/news/health-44777938 |title=Emerging sex disease 'could be superbug' |first=Michelle |last=Roberts |date=11 July 2018 |work=BBC News |access-date=11 July 2018 |archive-date=20 May 2022 |archive-url=https://web.archive.org/web/20220520074154/https://www.bbc.com/news/health-44777938 |url-status=live }}</ref>'','' '''Mgen''', or since 2018, '''''Mycoplasmoides genitalium'''''<ref name=":5">{{Cite journal |last1=Gupta |first1=Radhey S. |last2=Sawnani |first2=Sahil |last3=Adeolu |first3=Mobolaji |last4=Alnajar |first4=Seema |last5=Oren |first5=Aharon |date=2018-09-01 |title=Phylogenetic framework for the phylum Tenericutes based on genome sequence data: proposal for the creation of a new order Mycoplasmoidales ord. nov., containing two new families Mycoplasmoidaceae fam. nov. and Metamycoplasmataceae fam. nov. harbouring Eperythrozoon, Ureaplasma and five novel genera |url=https://doi.org/10.1007/s10482-018-1047-3 |journal=Antonie van Leeuwenhoek |language=en |volume=111 |issue=9 |pages=1583–1630 |doi=10.1007/s10482-018-1047-3 |pmid=29556819 |s2cid=254226604 |issn=1572-9699}}</ref>) is a [[sexually transmitted infection|sexually transmitted]],<ref>{{cite journal |author=Workowski K. A., Bolan G. A. |title=Sexually transmitted diseases treatment guidelines, 2015 |journal=MMWR Recomm. Rep. |volume=64 |issue=RR-03 |pages=1–137 |pmid=26042815 |pmc=5885289 |year=2015}}</ref> small and [[pathogenic]] [[bacterium]] that lives on the [[Mucous membrane|mucous]] [[Epithelium|epithelial cells]] of the [[urinary tract|urinary]] and [[genital tract]]s in humans.<ref name=":1">{{Cite journal |last1=Weinstein |first1=Scott A. |last2=Stiles |first2=Bradley G. |date=2012-01-01 |title=Recent perspectives in the diagnosis and evidence-based treatment of Mycoplasma genitalium |journal=Expert Review of Anti-infective Therapy |volume=10 |issue=4 |pages=487–499 |doi=10.1586/eri.12.20 |issn=1478-7210 |pmid=22512757 |s2cid=207218803}}</ref> Medical reports published in 2007 and 2015 state that Mgen is becoming increasingly common.<ref name=":2">{{cite journal |vauthors=Jensen JS, Bradshaw C |year=2015 |title=Management of Mycoplasma genitalium infections—Can we hit a moving target |journal=BMC Infect Dis |volume=15 |page=343 |doi=10.1186/s12879-015-1041-6 |pmid=26286546 |pmc=4545773 |doi-access=free }}</ref><ref>{{cite journal |vauthors=Manhart LE, Holmes KK, Hughes JP, etal |year=2007 |title=Mycoplasma genitalium among young adults in the United States: An emerging sexually transmitted infection |journal=Am J Public Health |volume=97 |issue=6 |pages=1118–1125 |doi=10.2105/ajph.2005.074062 |pmid=17463380 |pmc=1874220}}</ref> Resistance to multiple [[antibiotics]], including the [[macrolide]] [[azithromycin]], which until recently was the most reliable treatment, is becoming prevalent.<ref name=":2" /><ref>{{Citation |last1=Patel |first1=Parth H. |title=Macrolides |date=2023 |url=http://www.ncbi.nlm.nih.gov/books/NBK551495/ |work=StatPearls |access-date=2023-09-25 |place=Treasure Island (FL) |publisher=StatPearls Publishing |pmid=31855339 |last2=Hashmi |first2=Muhammad F.}}</ref> The bacterium was first isolated from the [[urogenital tract]] of humans in 1981,<ref name="tully81">{{cite journal |last1=Tully |first1=Joseph G. |last2=Cole |first2=Roger M. |last3=Taylor-Robinson |first3=David |last4=Rose |first4=David L. |title=A newly discovered ''Mycoplasma'' in the human urinogenital tract |journal=The Lancet |year=1981 |volume=317 |issue=8233 |pages=1288–1291 |doi=10.1016/S0140-6736(81)92461-2 |pmid=6112607 |s2cid=31023747}}</ref> and was eventually identified as a new species of ''[[Mycoplasma]]'' in 1983.<ref name="tully83">{{cite journal |last1=Tully |first1=J. G. |last2=Taylor-Robinson |first2=D. |last3=Rose |first3=D. L. |last4=Cole |first4=R. M. |last5=Bove |first5=J. M. |title=''Mycoplasma genitalium'', a New Species from the Human Urogenital Tract |journal=International Journal of Systematic Bacteriology |year=1983 |volume=33 |issue=2 |pages=387–396 |doi=10.1099/00207713-33-2-387 |doi-access=free }}</ref> It can cause negative health effects in men and women. It also increases the risk for [[HIV]] spread<ref>World Health Organization (WHO). Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus. Switzerland: World Health Organization 2013</ref> with higher occurrences in those previously treated with the [[azithromycin]] [[antibiotics]].<ref name=":2" /><ref>Barberá M, et al. Mycoplasma genitalium macrolide and fluoroquino-lone resistance: prevalence and risk factors among a 2013–2014 cohort of patients in Barcelona Sexually Transmitted Diseases: Spain, 2017; In Press</ref>

==Symptoms of infection==
Mgen is a bacterium recognized for causing [[urethritis]] in both men and women along with [[cervicitis]] and [[Pelvic inflammatory disease|pelvic inflammation]] in women.<ref name=":0">{{Cite journal |last1=Wiesenfeld |first1=Harold C. |last2=Manhart |first2=Lisa E. |date=2017-07-15 |title=Mycoplasma genitalium in Women: Current Knowledge and Research Priorities for This Recently Emerged Pathogen |journal=The Journal of Infectious Diseases |volume=216 |issue=suppl_2 |pages=S389–S395 |doi=10.1093/infdis/jix198 |issn=1537-6613 |pmc=5853983 |pmid=28838078}}</ref> It presents clinically similar symptoms to that of ''[[Chlamydia trachomatis]]'' infection and has shown higher incidence rates, compared to both ''Chlamydia trachomatis'' and ''[[Neisseria gonorrhoeae]]'' infections in some populations.<ref>{{cite journal |vauthors=Miller WC, Ford CA, Morris M, etal |year=2004 |title=Prevalence of chlamydial and gonococcal infections among young adults in the United States |journal=JAMA |volume=291 |issue=18 |pages=2229–2236 |doi=10.1001/jama.291.18.2229 |pmid=15138245 |doi-access=free}}</ref>

Infection with Mgen can be symptomatic or [[asymptomatic]]. Both men and women may experience [[inflammation]] in the [[urethra]] ([[urethritis]]), characterized by [[mucopurulent discharge]] in the [[Urinary system|urinary tract]], and [[Dysuria|burning while urinating]]. In women, it causes [[cervicitis]] and [[pelvic inflammatory disease|pelvic inflammatory diseases (PID)]], including [[endometritis]] and [[salpingitis]].<ref name=":0" /> Women may also experience bleeding after sex and it is also linked with [[infertility|tubal factor infertility]].<ref name=":1" /><ref>{{cite journal |last1=Manhart |first1=Lisa E. |title=''Mycoplasma genitalium'': An emergent sexually transmitted disease? |journal=Infectious Disease Clinics of North America |year=2013 |volume=27 |issue=4 |pages=779–792 |doi=10.1016/j.idc.2013.08.003 |pmid=24275270}}</ref><ref>{{Cite book |title=Williams gynecology |others=Schorge, John O.,, Hoffman, Barbara L.,, Bradshaw, Karen D.,, Halvorson, Lisa M.,, Schaffer, Joseph I.,, Corton, Marlene M. |isbn=978-0-07-184908-1 |edition=Third |location=New York |pages=65 |oclc=944920918 |last1=Schorge |first1=John O. |last2=Halvorson |first2=Lisa M. |last3=Schaffer |first3=Joseph I. |last4=Corton |first4=Marlene M. |last5=Bradshaw |first5=Karen D. |last6=Hoffman |first6=Barbara L. |date=2016-04-22}}</ref> For men, the most common signs are painful urination or a watery discharge from the penis.<ref name="cnn.com">{{cite web |url=http://www.cnn.com/2015/12/07/health/what-to-know-std-mg/index.html |title=What you should know about this 'new' STD - CNN |first=Kristine Thomason |last=Health.com |website=[[CNN]] |date=7 December 2015 |access-date=7 December 2015 |archive-date=3 October 2020 |archive-url=https://web.archive.org/web/20201003021831/https://www.cnn.com/2015/12/07/health/what-to-know-std-mg/index.html |url-status=live }}</ref>

There is a consistent association of ''M. genitalium'' infection and female reproductive tract syndromes. ''M. genitalium'' infection was significantly associated with increased risk of preterm birth, spontaneous abortion, cervicitis, and pelvic inflammatory disease. In addition, this pathogen may latently infect the [[chorionic villi]] tissues of pregnant women, thereby impacting pregnancy outcome.<ref>{{cite journal |vauthors=Contini C, Rotondo JC, Magagnoli F, Maritati M, Seraceni S, Graziano A, Poggi A, Capucci R, Vesce F, Tognon M, Martini F |date=2018 |title=Investigation on silent bacterial infections in specimens from pregnant women affected by spontaneous miscarriage. |journal=J Cell Physiol |volume=234 |issue=1 |pages=100–9107 |doi=10.1002/jcp.26952 |pmid=30078192 |doi-access=free|hdl=11392/2393176 |hdl-access=free }}</ref> Infertility risk is also strongly associated with infection with ''M. genitalium'', although evidence suggests it is not associated with male infertility.<ref name="pmid26311339">
{{cite journal |author1=C. Huang |author2=H.L. Zhu |author3=K.R. Xu |author4=S.Y. Wang |author5=L.Q. Fan |author6=W.B. Zhu |date=September 2015 |title=Mycoplasma and ureaplasma infection and male infertility: a systematic review and meta-analysis |journal=Andrology |volume=3 |issue=5 |pages=809–816 |doi=10.1111/andr.12078 |pmid=26311339 |s2cid=39834287 |doi-access=free}}
</ref> When ''M. genitalium'' is a co-infectious agent risk associations are stronger and statistically significant.<ref name="LisRowhani-Rahbar2015">{{cite journal |last1=Lis |first1=R. |last2=Rowhani-Rahbar |first2=A. |last3=Manhart |first3=L. E. |year=2015 |title=''Mycoplasma genitalium'' Infection and Female Reproductive Tract Disease: A Meta-Analysis |journal=Clinical Infectious Diseases |volume=61 |issue=3 |pages=418–426 |doi=10.1093/cid/civ312 |issn=1058-4838 |pmid=25900174 |doi-access=free |hdl-access=free |hdl=1773/26479}}</ref>

[[Polymerase chain reaction]] analyses indicated that it is a cause of acute [[non-gonococcal urethritis]] (NGU) and probably chronic NGU. It is strongly associated with persistent and recurring non-gonococcal urethritis (NGU), responsible for 15 percent to 20 percent of [[Symptomatic treatment|symptomatic]] NGU cases in men.<ref>Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin InfeAIDSct Dis. 2015;61(3):418-426</ref> Unlike other mycoplasmas, the infection is not associated with [[bacterial vaginosis]].<ref>{{cite journal |last1=Taylor-Robinson |first1=D. |title=''Mycoplasma genitalium'' – an up-date |journal=International Journal of STD & AIDS |year=2002 |volume=13 |issue=3 |pages=145–151 |doi=10.1258/0956462021924776 |pmid=11860689 |s2cid=11458681}}</ref> It is highly associated with the intensity of HIV infection.<ref>{{cite journal |last1=Weinstein |first1=Scott A |last2=Stiles |first2=Bradley G |title=Recent perspectives in the diagnosis and evidence-based treatment of |journal=Expert Review of Anti-infective Therapy |year=2013 |volume=10 |issue=4 |pages=487–499 |doi=10.1586/eri.12.20 |pmid=22512757 |s2cid=207218803}}</ref> Some scientists are performing research to determine if Mgen could play a role in the development of [[prostate cancer|prostate]] and [[ovarian cancer]]s and [[lymphomas]] in some individuals. These studies have yet to find conclusive evidence to suggest a link.<ref name="ZareiRezania2013">{{cite journal |last1=Zarei |first1=Omid |last2=Rezania |first2=Simin |last3=Mousavi |first3=Atefeh |title=''Mycoplasma genitalium'' and Cancer: A Brief Review |journal=Asian Pacific Journal of Cancer Prevention |volume=14 |issue=6 |year=2013 |pages=3425–3428 |issn=1513-7368 |doi=10.7314/APJCP.2013.14.6.3425 |pmid=23886122 |doi-access=free}}</ref>

==Genome==
[[File:Mycoplasma genitalium.gif|thumb|[[Gene map]] of ''Mycoplasma genitalium''. Circularly arranged coloured bands are the protein-coding genes and other loci in their position in the DNA. The genome has 580,070 [[base pair]]s (580 kb).]]
[[File:3D Whole Cell (3D-WC) model of a Mycoplasma genitalium cell Cubic section.jpg|thumb|upright=1.5|3D model of the ''Mycoplasma genitalium'' cell obtained with [[CellPACKgpu]]. The horizontal clipping plane shows the cytoplasmic environment on top and the membrane with associated proteins in the bottom. An additional clipping plane carves out a cubic section of the model, magnified on the right. Proteins colored by biological function.]]

The genome of ''M. genitalium'' strain G37<sup>T</sup> consists in one circular DNA molecule of 580,070 [[base pairs]].<ref name="fraser">{{cite journal |last1=Fraser |first1=C. M. |last2=Gocayne |first2=J. D. |last3=White |first3=O. |last4=Adams |first4=M. D. |last5=Clayton |first5=R. A. |last6=Fleischmann |first6=R. D. |last7=Bult |first7=C. J. |last8=Kerlavage |first8=A. R. |last9=Sutton |first9=G. |last10=Kelley |first10=J. M. |last11=Fritchman |first11=J. L. |last12=Weidman |first12=J. F. |last13=Small |first13=K. V. |last14=Sandusky |first14=M. |last15=Fuhrmann |first15=J. |year=1995 |title=The Minimal Gene Complement of ''Mycoplasma genitalium'' |journal=Science |volume=270 |issue=5235 |pages=397–404 |bibcode=1995Sci...270..397F |doi=10.1126/science.270.5235.397 |pmid=7569993 |s2cid=29825758 |last16=Nguyen |first16=D. |last17=Utterback |first17=T. R. |last18=Saudek |first18=D. M. |last19=Phillips |first19=C. A. |last20=Merrick |first20=J. M. |last21=Tomb |first21=J.-F. |last22=Dougherty |first22=B. A. |last23=Bott |first23=K. F. |last24=Hu |first24=P.-C. |last25=Lucier |first25=T. S.}}</ref> Scott N. Peterson and his team at the [[University of North Carolina at Chapel Hill]] reported the first genetic map using [[pulsed-field gel electrophoresis]] in 1991.<ref>{{cite journal |last1=Peterson |first1=Scott N. |last2=Schramm |first2=Nara |last3=Hu |first3=Ping-chuan |last4=Bott |first4=Kenneth F. |last5=Hutchison |first5=Clyde A. |title=A random sequencing approach for placing markers on the physical map of |journal=Nucleic Acids Research |date=1991 |volume=19 |issue=21 |pages=6027–6031 |doi=10.1093/nar/19.21.6027 |pmid=1945886 |pmc=329062}}</ref> They performed an initial study of the genome using [[DNA sequencing|sequencing]] in 1993, by which they found 100,993 nucleotides and 390 protein-coding genes.<ref>{{cite journal |last1=Peterson |first1=SN |last2=Hu |first2=PC |last3=Bott |first3=KF |last4=Hutchison |first4=CA |title=A survey of the ''Mycoplasma genitalium'' genome by using random sequencing |journal=Journal of Bacteriology |year=1993 |volume=175 |issue=24 |pages=7918–7930 |pmid=8253680 |pmc=206970 |doi=10.1128/jb.175.24.7918-7930.1993}}</ref> Collaborating with researchers at The [[Institute for Genomic Research]] (TIGR; now the J. Craig Venter Institute), which included [[Craig Venter]], they made the complete genome sequence in 1995 using [[shotgun sequencing]].<ref name=fraser/> Only 470 predicted [[coding region]]s were identified in 1995, including [[gene]]s required for [[DNA replication]], [[gene transcription|transcription]] and [[gene translation|translation]], [[DNA repair]], [[cellular transport]], and [[energy metabolism]]. It was the second complete bacterial genome ever sequenced, after ''[[Haemophilus influenzae]]''.<ref name=fraser/> Later data from [[KEGG]] reports 476 protein-coding genes and 43 [[Non-coding RNA|RNA gene]]s, totaling 519.<ref>{{cite web |title=KEGG GENOME: Mycoplasmoides genitalium G37 |url=https://www.genome.jp/entry/gn:T00002 |website=www.genome.jp}}</ref> It is unclear where the "525" gene count for the G37<sup>T</sup> stems from and what [[GeneCalling|gene calling]] procedure was used.<ref>{{cite journal |last1=Karr |first1=JR |last2=Sanghvi |first2=JC |last3=Macklin |first3=DN |last4=Gutschow |first4=MV |last5=Jacobs |first5=JM |last6=Bolival B |first6=Jr |last7=Assad-Garcia |first7=N |last8=Glass |first8=JI |last9=Covert |first9=MW |title=A whole-cell computational model predicts phenotype from genotype. |journal=Cell |date=20 July 2012 |volume=150 |issue=2 |pages=389–401 |doi=10.1016/j.cell.2012.05.044 |pmid=22817898|pmc=3413483 |doi-access=free }}</ref>

In 2006, the team at the J. Craig Venter Institute reported that only 382 genes are essential for biological functions.<ref>{{cite journal |last1=Glass |first1=J. I. |last2=Assad-Garcia |first2=N. |last3=Alperovich |first3=N. |last4=Yooseph |first4=S. |last5=Lewis |first5=M. R. |last6=Maruf |first6=M. |last7=Hutchison |first7=C. A. |last8=Smith |first8=H. O. |last9=Venter |first9=J. C. |title=Essential genes of a minimal bacterium |journal=Proceedings of the National Academy of Sciences |date=2006 |volume=103 |issue=2 |pages=425–430 |doi=10.1073/pnas.0510013103 |pmid=16407165 |pmc=1324956 |bibcode=2006PNAS..103..425G |doi-access=free}}</ref> The small genome of ''M. genitalium'' made it the organism of choice in [[The Minimal Genome Project]], a study to find the smallest set of genetic material necessary to sustain [[life]].<ref>{{cite journal |last1=Razin |first1=S |title=The minimal cellular genome of mycoplasma |journal=Indian Journal of Biochemistry & Biophysics |year=1997 |volume=34 |issue=1–2 |pages=124–30 |pmid=9343940}}</ref>

There is limited divergence among clinical strains of ''M. genitalium''. All strains retain the small genome size.<ref>{{cite journal |last1=Fookes |first1=MC |last2=Hadfield |first2=J |last3=Harris |first3=S |last4=Parmar |first4=S |last5=Unemo |first5=M |last6=Jensen |first6=JS |last7=Thomson |first7=NR |title=Mycoplasma genitalium: whole genome sequence analysis, recombination and population structure. |journal=BMC Genomics |date=28 December 2017 |volume=18 |issue=1 |pages=993 |doi=10.1186/s12864-017-4399-6 |pmid=29281972|pmc=5745988 |doi-access=free }}</ref>

==Diagnosis==
Recent research shows that prevalence of Mgen is currently higher than other commonly occurring [[sexually transmitted infection]]s (STIs).<ref>{{cite journal |author=Taylor-Robinson D, Jensen JS |year=2011 |title=Mycoplasma genitalium: from chrysalis to multicolored butterfly |journal=Clin Microbiol Rev |volume=24 |issue=3 |pages=498–514 |doi=10.1128/cmr.00006-11 |pmid=21734246 |pmc=3131060}}</ref> Mgen is a fastidious organism with prolonged growth durations. This makes detection of the pathogen in clinical specimens and subsequent isolation extremely difficult.<ref>{{cite journal |author=Jensen J. S., Hansen H. T., Lind K. |year=1996 |title=Isolation of Mycoplasma genitalium strains from the male urethra |journal=J. Clin. Microbiol. |volume=34 |issue=2 |pages=286–291 |doi=10.1128/jcm.34.2.286-291.1996 |pmid=8789002 |pmc=228784 |doi-access=free}}</ref> Lacking a [[cell wall]], [[Mycoplasma]] remains unaffected by commonly used [[antibiotics]].<ref>Centers for Disease Control and Prevention, 2015 Sexually Transmitted Diseases Treatment Guidelines.</ref> The absence of specific serological assays leaves [[nucleic acid amplification tests]] (NAAT) as the only viable option for detection of Mgen [[DNA]] or [[RNA]].<ref name=":3"/> However, samples with positive NAAT for the pathogen should be tested for [[macrolide]] resistance [[mutation]]s, which are strongly correlated to [[azithromycin]] treatment failures, owing to rapid rates of mutation of the pathogen.<ref name=":2" /> Mutations in the [[23S rRNA (guanine745-N1)-methyltransferase|23S rRNA]] gene of Mgen have been linked with clinical treatment failure and high level [[In vitro maturation|in vitro]] macrolide resistance.<ref>{{cite journal |vauthors=Jensen JS, etal |year=2008 |title=Azithromycin Treatment Failure in Mycoplasma genitalium–Positive Patients with Nongonococcal Urethritis Is Associated with Induced Macrolide Resistance |journal=Clin. Infect. Dis. |volume=47 |issue=12 |pages=1546–1553 |doi=10.1086/593188 |pmid=18990060 |doi-access=}}</ref> Macrolide resistance mediating mutations have been observed in 20-50% of cases in the UK, Denmark, Sweden, Australia, and Japan.<ref name=":2" /> Resistance is also developing towards the second-line [[antimicrobial]]s like [[fluoroquinolone]].<ref>Unemo, M. & Jensen, J.S. 'Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium'. 2016. Nat. Rev. Urol..268. Published online 10 January 2017. doi:10.1038/nrurol</ref>

According to the European guidelines, the indication for commencement of diagnosis for Mgen infection are:<ref name=":3">{{cite journal| author=Jensen JS, Cusini M, Gomberg M, Moi H| title=2016 European guideline on Mycoplasma genitalium infections. | journal=J Eur Acad Dermatol Venereol | year= 2016 | volume= 30 | issue= 10 | pages= 1650–1656 | pmid=27505296 | doi=10.1111/jdv.13849 | pmc= | doi-access=free }}</ref>

# Detection of nucleic acid (DNA and/or RNA) specific for Mgen in a clinical specimen
# Current partners of individuals who tested positive for Mgen should be treated with the same antimicrobial as the [[index patient]]
# If current partner does not attend for evaluation and testing, treatment with the same regimen as given to the index patient should be offered on [[Epidemiology|epidemiological]] grounds
# On epidemiological grounds for sexual contacts in the previous 3 months; ideally, specimens for a Mgen NAAT should be collected before treatment and treatment should not be given before the result are available

Screening for Mgen with a combination of detection and macrolide resistance mutations will provide the adequate information required to develop personalised antimicrobial treatments, in order to optimise patient management and control the spread of [[antimicrobial resistance]] (AMR).<ref name=":3" /><ref name=":4">Tabrizi SN et al. Multiplex Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance Using PlexZyme and PlexPrime Technology. PLoS ONE. 2016. 11(6): e0156740. doi:10.1371/journal.pone.0156740</ref>

===Detection of resistance===
Owing to the widespread [[Macrolide|macrolide resistance]], samples that are positive for Mgen should ideally be followed up with an assay capable of detecting mutations that mediate antimicrobial resistance. The European Guideline on Mgen infections recommend complementing the molecular detection of Mgen with an assay capable of detecting macrolide resistance-associated mutations. Furthermore, molecular assays for quinolone resistance-associated mutations are available at specialised laboratories in suspected treatment failure due to treatment with moxifloxacin.<ref>{{Cite journal |last=Jensen |first=J.S. |last2=Cusini |first2=M. |last3=Gomberg |first3=M. |last4=Moi |first4=H. |last5=Wilson |first5=J. |last6=Unemo |first6=M. |date=May 2022 |title=2021 European guideline on the management of Mycoplasma genitalium infections |url=https://onlinelibrary.wiley.com/doi/10.1111/jdv.17972 |journal=Journal of the European Academy of Dermatology and Venereology |language=en |volume=36 |issue=5 |pages=641–650 |doi=10.1111/jdv.17972 |issn=0926-9959}}</ref>

==Treatment==
The U.S. [[Centers for Disease Control and Prevention]] recommends a step-wise treatment approach for ''Mycoplasma genitalium'' with [[doxycycline]] for seven days followed immediately by a seven-day course of [[moxifloxacin]] as the preferred therapy due to high rates of macrolide resistance.<ref name="pmid38331481"/><ref name="JAMA Tuddenham">{{cite journal |last1=Tuddenham |first1=Susan |last2=Hamill |first2=Matthew M. |last3=Ghanem |first3=Khalil G. |title=Diagnosis and Treatment of Sexually Transmitted Infections: A Review |journal=JAMA |date=11 January 2022 |volume=327 |issue=2 |pages=161–172 |doi=10.1001/jama.2021.23487 |pmid=35015033|s2cid=245855151 }}</ref><ref name="CDC 2021 guidelines" /> If resistance assay testing is available, and the Mgen is sensitive to macrolides, the CDC recommends a seven-day course of doxycycline followed by a four-day course of [[azithromycin]].<ref name="pmid38331481">{{cite journal |vauthors=Obafemi OA, Rowan SE, Nishiyama M, Wendel KA |title=Mycoplasma genitalium: Key Information for the Primary Care Clinician |journal=Med Clin North Am |volume=108 |issue=2 |pages=297–310 |date=March 2024 |pmid=38331481 |doi=10.1016/j.mcna.2023.07.004}}</ref>  Although the majority of ''M. genitalium'' strains are sensitive to moxifloxacin, resistance has been reported, and potential for serious, adverse side effects should be considered with this regimen. <ref>{{Cite web |title=Food and Drug Administration |url=//www.fda.gov/news-events/press-announcements/fda-updates-warnings-fluoroquinolone-antibiotics-risks-mental-health-and-low-blood-sugar-adverse |website=FDA}}</ref> Floroquinolones, including moxifloxacin, have been associated with disabling and potentially irreversible serious adverse reactions that have occurred together including:{{cn|date=January 2023}}
* Tendinitis and tendon rupture
* Peripheral Neuropathy
* Central nervous system effects

and other serious side effects detailed in the FDA black box warning. Moxifloxacin/Avelox should be reserved for use when patients have no other treatment options. <ref>{{Cite web |title=Access Data FDA |url=https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021085s063lbl.pdf}}</ref>

In settings without access to resistance testing, or if moxifloxacin cannot be used, the CDC recommends as an alternative regimen: seven days of doxycycline followed by the four-day course of azithromycin, with a test of cure 21 days after treatment being required due to the high rate of macrolide resistance.  [[Beta-lactam antibiotic|Beta lactam antibiotics]] are not effective against Mgen as the organism lacks a cell wall.<ref name="CDC 2021 guidelines">{{cite journal |last1=Workowski |first1=Kimberly A. |title=Sexually Transmitted Infections Treatment Guidelines, 2021 |journal=MMWR. Recommendations and Reports |date=2021 |volume=70 |issue=4 |pages=1–187 |doi=10.15585/mmwr.rr7004a1 |pmid=34292926 |pmc=8344968}}</ref>

In the UK the British Association for Sexual Health and HIV (BASHH) guidelines for treatment are:<ref>{{cite web|url=https://www.bashh.org/guidelines|title=BASHH Guidelines|date=13 March 2015 }}</ref>
* Doxycycline 100mg twice a day for seven days followed by azithromycin 1 gram orally as a single dose then 500mg orally once daily for 2 days where organism is known to be macrolide-sensitive or where resistance status is unknown.
* Moxifloxacin 400mg orally once daily for 10 days if organism known to be macrolide-resistant or where treatment with azithromycin has failed.

Treatment of ''Mycoplasma genitalium'' infections is becoming increasingly difficult due to rapidly growing [[antimicrobial resistance]].<ref>{{Cite web |url=https://www.who.int/yaws/2013_Yaws_seminar_Lancet.pdf?ua=1&ua=1 |title=Yaws |date=2013 |website=World Health Organization |access-date=8 December 2017 |archive-date=29 November 2021 |archive-url=https://web.archive.org/web/20211129193615/https://www.who.int/yaws/2013_Yaws_seminar_Lancet.pdf?ua=1&ua=1 |url-status=live }}</ref> Diagnosis and treatment is further hampered by the fact that ''Mycoplasma genitalium'' infections are not routinely tested.<ref>{{cite journal |last1=Suneta |first1=Soni |last2=Parkhouse |first2=Andy |last3=Gillian |first3=Dean |date=24 April 2017 |title=Macrolide and quinolone-resistant ''Mycoplasma genitalium'' in a man with persistent urethritis: the tip of the British iceberg? |journal=Sexually Transmitted Infections |volume=93 |issue=8 |doi=10.1136/sextrans-2016-053077 |pmid=28438948 |pages=sextrans–2016–053077 |s2cid=9178150}}</ref> Studies have demonstrated that a 5-day course of azithromycin has a superior cure rate compared to a single, larger dose. Further, a single dose of azithromycin can lead to the bacteria becoming resistant to azithromycin.<ref>{{cite journal |last1=Yew |first1=H. S. |last2=Anderson |first2=T. |last3=Coughlan |first3=E. |last4=Werno |first4=A. |title=Induced macrolide resistance in ''Mycoplasma genitalium'' isolates from patients with recurrent nongonococcal urethritis |journal=Journal of Clinical Microbiology |year=2011 |volume=49 |issue=4 |pages=1695–1696 |doi=10.1128/JCM.02475-10 |pmid=21346049 |pmc=3122813}}</ref> Among Swedish patients, doxycycline was shown to be relatively ineffective (with a cure rate of 48% for women and 38% for men); and treatment with a single dose of azithromycin is not prescribed due to it inducing antimicrobial resistance. The five-day treatment with azithromycin showed no development of antimicrobial resistance.<ref>{{cite journal |last1=Anagrius |first1=Carin |last2=Loré |first2=Britta |last3=Jensen |first3=Jørgen Skov |last4=Coenye |first4=Tom |title=Treatment of ''Mycoplasma genitalium''. Observations from a Swedish STD Clinic |journal=PLOS ONE |year=2013 |volume=8 |issue=4 |pages=e61481 |doi=10.1371/journal.pone.0061481 |pmid=23593483 |pmc=3620223 |bibcode=2013PLoSO...861481A |doi-access=free}}</ref> Based on these findings, UK doctors are moving to the 5-day azithromycin regimen. Doxycycline is also still used, and [[moxifloxacin]] is used as a second-line treatment in case doxycyline and azithromycin are not able to eradicate the infection.<ref name="Jorgen S 2016">{{cite journal |last1=Unemo |first1=Magnus |last2=Jensen |first2=Jorgen S. |date=10 January 2017 |title=Antimicrobial-resistant sexually transmitted infections: gonorrhoea and ''Mycoplasma genitalium'' |journal=Nature Reviews Urology |volume=14 |issue=3 |pages=139–125 |doi=10.1038/nrurol.2016.268 |pmid=28072403 |s2cid=205521926}}</ref><ref>{{cite web |url=http://www.theonlineclinic.co.uk/news/2012/12/20/MycoplasmaGenitaliumTreatmentChoices.aspx |title=Mycoplasma Genitalium Treatment Choices |website=www.theonlineclinic.co.uk |access-date=21 December 2012 |archive-date=24 June 2021 |archive-url=https://web.archive.org/web/20210624210015/https://www.theonlineclinic.co.uk/news/2012/12/20/MycoplasmaGenitaliumTreatmentChoices.aspx |url-status=live }}</ref>
In patients where doxycycline, azithromycin and moxifloxacin all failed, [[pristinamycin]] has been shown to still be able to eradicate the infection.<ref name="Jorgen S 2016"/>

==History==
''Mycoplasma genitalium'' was originally isolated in 1980 from [[urethra]]l [[Biological specimen|specimen]]s of two male patients with [[non-gonococcal urethritis]] in the genitourinary medicine (GUM) clinic at [[St Mary's Hospital, London|St Mary's Hospital, Paddington]], London.<ref>{{cite journal |last1=Taylor-Robinson |first1=D. |last2=Horner |first2=P. J. |title=The role of ''Mycoplasma genitalium'' in non-gonococcal urethritis |journal=Sexually Transmitted Infections |year=2001 |volume=77 |issue=4 |pages=229–231 |doi=10.1136/sti.77.4.229 |pmid=11463919 |pmc=1744340}}</ref><ref>{{cite journal |last1=Daley |first1=G. |last2=Russell |first2=D. |last3=Tabrizi |first3=S. |last4=McBride |first4=J. |title=''Mycoplasma genitalium'': a review |journal=International Journal of STD & AIDS |year=2014 |volume=25 |issue=7 |pages=475–487 |doi=10.1177/0956462413515196 |pmid=24517928 |s2cid=206582691}}</ref> It was reported in 1981 by a team led by Joseph G. Tully.<ref name=tully81/> Under electron microscopy, it appears as a flask-shaped cell with a narrow terminal portion that is crucial for its attachment to the host cell surfaces.<ref>{{cite journal |last1=Taylor-Robinson |first1=D |title=The Harrison Lecture. The history and role of ''Mycoplasma genitalium'' in sexually transmitted diseases |journal=Genitourinary Medicine |year=1995 |volume=71 |issue=1 |pages=1–8 |pmid=7750946 |pmc=1195360 |doi=10.1136/sti.71.1.1}}</ref> The bacterial cell is slightly elongated somewhat like a vase, and measures 0.6–0.7 μm in length, 0.3–0.4 μm at the broadest region, and 0.06–0.08 μm at the tip. The base is broad while the tip is stretched into a narrow neck, which terminates with a cap. The terminal region has a specialised region called nap, which is absent in other mycoplasmas. [[Serological testing|Serological tests]] indicated that the bacterium was not related to known species of ''Mycoplasma''. The comparison of genome sequences with other urinogenital bacteria, such as ''[[Mycoplasma hominis|M. hominis]]'' and ''[[Ureaplasma parvum]]'', revealed that ''M. genitalium'' is significantly different, especially in the [[Metabolic pathways|energy-generating pathways]], although it shared a core genome of ~250 protein-encoding genes.<ref>{{cite journal |last1=Blanchard |first1=Alain |last2=Bébéar |first2=Cécile |title=The evolution of ''Mycoplasma genitalium'' |journal=Annals of the New York Academy of Sciences |year=2011 |volume=1230 |issue=1 |pages=E61–E64 |doi=10.1111/j.1749-6632.2011.06418.x |pmid=22417108 |bibcode=2011NYASA1230E..61B |s2cid=32057598}}</ref>

In 2018, Gupta et al. proposed to change the name of ''Mycoplasma genitalium'' to ''Mycoplasmoides genitalium'' on phylogenetic grounds, reflecting the existing knowledge that ''M. genitalium'' is not very related to other ''Mycoplasma''.<ref name=":5" /> The change became [[correct name]] under the [[International Code of Nomenclature of Prokaryotes]] (ICNP, "Code") with Validation List 184, published by the [[International Committee on Systematics of Prokaryotes|ICSP]] ("Committee").<ref name="ipsn_gen">{{cite web |title=Genus: Mycoplasmoides |url=https://lpsn.dsmz.de/genus/mycoplasmoides |website=lpsn.dsmz.de |language=en}}</ref> Mycoplasmaologists working in the field generally oppose this renaming. In 2019, they published an opinion paper arguing that even though the phylogenetic methods are valid, Gupta's renaming scheme causes too many changes, which is impractical and confusing.<ref name=":6">{{Cite journal |last1=Balish |first1=Mitchell |last2=Bertaccini |first2=Assunta |last3=Blanchard |first3=Alain |last4=Brown |first4=Daniel |last5=Browning |first5=Glenn |last6=Chalker |first6=Victoria |last7=Frey |first7=Joachim |last8=Gasparich |first8=Gail |last9=Hoelzle |first9=Ludwig |last10=Knight |first10=Tom |last11=Knox |first11=Christine |last12=Kuo |first12=Chih-Horng |last13=Manso-Silván |first13=Lucia |last14=May |first14=Meghan |last15=Pollack |first15=J. Dennis |date=2019 |title=Recommended rejection of the names Malacoplasma gen. nov., Mesomycoplasma gen. nov., Metamycoplasma gen. nov., Metamycoplasmataceae fam. nov., Mycoplasmoidaceae fam. nov., Mycoplasmoidales ord. nov., Mycoplasmoides gen. nov., Mycoplasmopsis gen. nov. [Gupta, Sawnani, Adeolu, Alnajar and Oren 2018] and all proposed species comb. nov. placed therein |journal=International Journal of Systematic and Evolutionary Microbiology |volume=69 |issue=11 |pages=3650–3653 |doi=10.1099/ijsem.0.003632 |pmid=31385780 |issn=1466-5034|doi-access=free |hdl=11585/720151 |hdl-access=free }}</ref> They cite some essential principles of the Code, such as "no unnecessary new names", "aim at stability of names", and "avoid or reject the use of names which may cause error or confusion".<ref name=":6" /> However, the 2019 argument for preserving old names was rejected by the Committee in Opinion 122 of 2022,<ref name=Arahal>{{cite journal |last1=Arahal |first1=David R. |last2=Busse |first2=Hans-Jürgen |last3=Bull |first3=Carolee T. |last4=Christensen |first4=Henrik |last5=Chuvochina |first5=Maria |last6=Dedysh |first6=Svetlana N. |last7=Fournier |first7=Pierre-Edouard |last8=Konstantinidis |first8=Konstantinos T. |last9=Parker |first9=Charles T. |last10=Rossello-Mora |first10=Ramon |last11=Ventosa |first11=Antonio |last12=Göker |first12=Markus |title=Judicial Opinions 112–122 |journal=International Journal of Systematic and Evolutionary Microbiology |date=10 August 2022 |volume=72 |issue=8 |doi=10.1099/ijsem.0.005481 |pmid=35947640 |s2cid=251470203 |url=https://www.researchgate.net/publication/362626093}}</ref> where it was ruled that the argument incorrectly cited the Code.<ref name="ipsn_gen"/> The Opinion emphasizes that use of an older [[validly published name]] remains acceptable under the Code.<ref name=Arahal/>

==Synthetic genome==
On 6 October 2007, [[Craig Venter]] announced that a team of scientists led by Nobel laureate [[Hamilton O. Smith|Hamilton Smith]] at the J. Craig Venter Institute had successfully constructed [[synthetic DNA]] with which they planned to make the first synthetic genome. Reporting in ''[[The Guardian]]'', Venter said that they had stitched together a DNA strand containing 381 genes, consisting of 580,000 base pairs, based on the genome of ''M. genitalium''.<ref>{{cite news |last1=Pilkington |first1=Ed |title=I am creating artificial life, declares US gene pioneer |url=https://www.theguardian.com/science/2007/oct/06/genetics.climatechange |access-date=9 August 2014 |work=The Guardian |publisher=Guardian News and Media Limited |date=6 October 2007 |archive-date=28 May 2010 |archive-url=https://web.archive.org/web/20100528172927/http://www.guardian.co.uk/science/2007/oct/06/genetics.climatechange |url-status=live }}</ref> On 24 January 2008, they announced the successful creation of a synthetic bacterium, which they named ''Mycoplasma genitalium'' JCVI-1.0 (the name of the strain indicating J. Craig Venter Institute with its specimen number).<ref>{{cite web |last1=Kowalski |first1=Heather |title=Venter Institute Scientists Create First Synthetic Bacterial Genome |url=http://www.jcvi.org/cms/research/projects/synthetic-bacterial-genome/press-release/ |publisher=J. Craig Venter Institute |access-date=9 August 2014 |archive-date=11 July 2015 |archive-url=https://web.archive.org/web/20150711044023/http://www.jcvi.org/cms/research/projects/synthetic-bacterial-genome/press-release/ |url-status=dead }}</ref> They synthesised and assembled the complete 582,970-base pair genome of the bacterium. The final stages of synthesis involved cloning the DNA into the bacterium ''[[Escherichia coli|E. coli]]'' for nucleotide production and sequencing. This produced large fragments of approximately 144,000 base pairs or 1/4th of the whole genome. Finally, the products were cloned inside the yeast ''[[Saccharomyces cerevisiae]]'' to synthesize the 580,000 base pairs.<ref>{{cite journal |last1=Gibson |first1=D. G. |last2=Benders |first2=G. A. |last3=Andrews-Pfannkoch |first3=C. |last4=Denisova |first4=E. A. |last5=Baden-Tillson |first5=H. |last6=Zaveri |first6=J. |last7=Stockwell |first7=T. B. |last8=Brownley |first8=A. |last9=Thomas |first9=D. W.|last10=Algire|first10=M. A. |last11=Merryman |first11=C. |last12=Young |first12=L. |last13=Noskov |first13=V. N. |last14=Glass |first14=J. I. |last15=Venter |first15=J. C. |last16=Hutchison |first16=C. A. |last17=Smith |first17=H. O. |title=Complete Chemical Synthesis, Assembly, and Cloning of a ''Mycoplasma genitalium'' Genome |journal=Science |year=2008 |volume=319 |issue=5867 |pages=1215–1220 |doi=10.1126/science.1151721 |pmid=18218864 |bibcode=2008Sci...319.1215G |s2cid=8190996}}</ref><ref>{{cite news |first=Philip |last=Ball |title=Genome stitched together by hand |url=http://www.nature.com/news/2008/080124/full/news.2008.522.html |work=Nature News |date=2008-01-24 |doi=10.1038/news.2008.522 |access-date=25 January 2008 |archive-date=21 October 2020 |archive-url=https://web.archive.org/web/20201021002756/https://www.nature.com/news/2008/080124/full/news.2008.522.html |url-status=live }}</ref> The molecular size of the synthetic bacterial genome is 360,110 [[Unified atomic mass unit|kilodaltons]] (kDa). Printed in 10-point font, the letters of the genome cover 147 pages.<ref>{{cite web |title=Scientists Create First Synthetic Bacterial Genome -- Largest Chemically Defined Structure Synthesized In The Lab |url=https://www.sciencedaily.com/releases/2008/01/080124175924.htm |work=ScienceDaily |access-date=9 August 2014 |date=24 January 2008 |archive-date=10 August 2014 |archive-url=https://web.archive.org/web/20140810181302/http://www.sciencedaily.com/releases/2008/01/080124175924.htm |url-status=live }}</ref>

On 20 July 2012, [[Stanford University]] and the J. Craig Venter Institute announced successful simulation of the complete life cycle of a ''Mycoplasma genitalium'' cell, in the journal ''[[Cell (journal)|Cell]]''.<ref>{{cite journal |last1=Karr |first1=Jonathan R. |last2=Sanghvi |first2=Jayodita C. |last3=Macklin |first3=Derek N. |last4=Gutschow |first4=Miriam V. |last5=Jacobs |first5=Jared M. |last6=Bolival |first6=Benjamin |last7=Assad-Garcia |first7=Nacyra |last8=Glass |first8=John I. |last9=Covert |first9=Markus W. |title=A Whole-Cell Computational Model Predicts Phenotype from Genotype |journal=Cell |year=2010 |volume=150 |issue=2 |pages=389–401 |doi=10.1016/j.cell.2012.05.044 |pmid=22817898 |pmc=3413483}}</ref> The entire organism is modeled in terms of its molecular components, integrating all cellular processes into a single model. Using object oriented programming to model the interactions of 28 categories of molecules, including DNA, RNA, proteins, and metabolites, and running on a 128 computer Linux cluster, the simulation takes 10 hours for a single ''M. genitalium'' cell to divide once—about the same time the actual cell takes—and generates half a gigabyte of data.<ref>{{cite news |title=In First, Software Emulates Lifespan of Entire Organism |date=20 July 2012 |newspaper=[[The New York Times]] |access-date=2012-07-20 |url=https://www.nytimes.com/2012/07/21/science/in-a-first-an-entire-organism-is-simulated-by-software.html |archive-date=4 December 2016 |archive-url=https://web.archive.org/web/20161204042711/http://www.nytimes.com/2012/07/21/science/in-a-first-an-entire-organism-is-simulated-by-software.html?_r=3 |url-status=live }}</ref>

==Research==
The discovery of [[Protein M]], a protein produced by ''M. genitalium'', was announced in February 2014.<ref name=scripps>{{cite web |title=The Ultimate Decoy: Scripps Research Institute Scientists Find Protein that Helps Bacteria Misdirect Immune System |url=http://www.scripps.edu/news/press/2014/20140206lerner.html |publisher=The Scripps Research Institute (TSRI) |access-date=9 August 2014 |archive-date=4 June 2014 |archive-url=https://web.archive.org/web/20140604001536/http://www.scripps.edu/news/press/2014/20140206lerner.html |url-status=live }}</ref> The protein was identified during investigations on the origin of [[multiple myeloma]], a B-cell hematologic neoplasm. To understand the long-term ''Mycoplasma'' infection, it was found that [[antibodies]] from multiple myeloma patients' blood were recognised by ''M. genitalium''. The antibody reactivity was due to a protein, designated Protein M, that is chemically responsive to all types of human and nonhuman antibodies available. The protein is about 50 kDa in size, and composed of 556 amino acids.<ref>{{cite journal |last1=Grover |first1=R. K. |last2=Zhu |first2=X. |last3=Nieusma |first3=T. |last4=Jones |first4=T. |last5=Boero |first5=I. |last6=MacLeod |first6=A. S. |last7=Mark |first7=A. |last8=Niessen |first8=S. |last9=Kim |first9=H. J.|last10=Kong|first10=L. |last11=Assad-Garcia |first11=N. |last12=Kwon |first12=K. |last13=Chesi |first13=M. |last14=Smider |first14=V. V. |last15=Salomon |first15=D. R. |last16=Jelinek |first16=D. F. |last17=Kyle |first17=R. A. |last18=Pyles |first18=R. B. |last19=Glass |first19=J. I.|last20=Ward|first20=A. B. |last21=Wilson |first21=I. A. |last22=Lerner |first22=R. A. |title=A structurally distinct human mycoplasma protein that generically blocks antigen-antibody union |journal=Science |date=2014 |volume=343 |issue=6171 |pages=656–661 |doi=10.1126/science.1246135 |pmid=24503852 |pmc=3987992 |bibcode=2014Sci...343..656G}}</ref>

Mgen evolved from a gram-positive ancestor that was clostridium-like but has lost the genes to code for the enzymes involved in de novo nucleic acid synthesis, amino acid synthesis, and synthesis of fatty acids.<ref>{{cite journal |last1=Raj |first1=Stephen |title=Mycoplasma genitalium : A new superbug |journal=Indian Journal of Sexually Transmitted Diseases and AIDS |date=2022 |volume=43 |issue=2589–0557|pages=1–12 |doi=10.4103/ijstd.ijstd_103_20 |doi-access=free |pmid=35846530 |pmc=9282694 }}</ref> This means that Mgen needs the host's growth factors to keep reproducing. Although Mgen has abilities that help it adhere to cells, it is still unknown how the bacteria can maintain an infection inside the epithelial cells of the ectocervix and vagina when shedding of the apical layer of cells occur. The organism's ability to have adhesion to host cells relies of two proteins, P110 and P140. Adhesion is an important step in beginning an infection in a cell and Mgen can adhere to spermatozoa, erythrocytes, and epithelial cells. The terminal organelle relies on these proteins as well because without them the organelle was not present. The segmented pair plates of Mgen {{vague|date=November 2023}} is a core of dense electrons which is anchored to the cell membrane. The end of this core is in contact with the wheel complex and the wheel complex contains the proteins MG219, MG200, MG386, and MG491 which aid in the gliding motility of the bacteria. Although Mgen lacks secreted virulence factors, the protein MG186 degrades host nucleic acids due to it being a calcium-dependent membrane-associated nuclease.{{fact|date=November 2023}}

==See also==
* [[Smallest organisms]]

==References==
{{Reflist|30em}}

==External links==
* [https://webarchive.nationalarchives.gov.uk/ukgwa/20080228120000/http://www.hpa.org.uk/cfi/stbrl/Mycoplasma_genitalium_ref_work.htm ''Mycoplasma genitalium'' Reference Work] at the [[UK Health Protection Agency]]
* [https://bacdive.dsmz.de/strain/8605 Type strain of ''Mycoplasma genitalium'' at Bac''Dive'' - the Bacterial Diversity Metadatabase]

{{Gram-positive firmicutes diseases}}

{{Taxonbar|from=Q1930909}}
{{Use dmy dates|date=October 2019}}

[[Category:Mycoplasma|genitalium]]
[[Category:Model organisms]]
[[Category:Organism size]]
[[Category:Sexually transmitted diseases and infections]]
[[Category:Synthetic biology]]
[[Category:Bacteria described in 1983]]
[[Category:Pathogenic bacteria]]
[[Category:Infectious causes of cancer]]